Amikacin Sulfate

NDC 67184-0569 · Qilu Pharmaceutical Co., Ltd.

Generic nameAmikacin Sulfate

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)AMIKACIN SULFATE

Strength250 mg/mL

Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS]

Marketing categoryANDA

Packages

67184-0569-2 — 10 VIAL, GLASS in 1 CARTON (67184-0569-2) / 2 mL in 1 VIAL, GLASS (67184-0569-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0641-6166 — Amikacin Sulfate, 0641-6167 — Amikacin Sulfate, 23155-290 — Amikacin Sulfate, 23155-785 — Amikacin Sulfate, 23155-786 — Amikacin Sulfate, 25021-173 — amikacin sulfate, 63323-815 — Amikacin Sulfate, 67184-0570 — Amikacin Sulfate, 83301-0022 — Amikacin Sulfate, 83301-0023 — Amikacin Sulfate

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T36.5X1 — Poisoning by aminoglycosides, accidental (unintentional), T36.5X2 — Poisoning by aminoglycosides, intentional self-harm, T36.5X3 — Poisoning by aminoglycosides, assault, T36.5X4 — Poisoning by aminoglycosides, undetermined, T36.5X5 — Adverse effect of aminoglycosides, T36.5X6 — Underdosing of aminoglycosides

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.